Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service England.

Assuming the Black and African American subgroup of LIVE-AIR are representative of potential outcomes in the Black African and Black Caribbean persons in the UK, these findings may be significant since this demographic is disproportionally affected by COVID-19, with an increased rate of death. 41 As with extrapolation of any clinical trial results, this study had several limitations.

also in 13,097 other papers